Revvity (RVTY) Cash from Investing Activities Growth (1y) (2010 - 2026)
Powered by 
Analysis
Revvity (RVTY) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -3,832.95% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -975.00% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -148.98% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 81.42% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -1,838.18% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 42.20% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 73.35% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -723.75% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 72.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 81.42% |
| Apr 5, 2026 | -396.87% |
| Dec 28, 2025 | -18.02% |
| Sep 28, 2025 | -102.68% |
| Jun 29, 2025 | -115.53% |
| Mar 30, 2025 | 13.35% |
| Dec 29, 2024 | 95.82% |
| Sep 29, 2024 | 58.71% |
| Jun 30, 2024 | 121.28% |
| Mar 31, 2024 | -100.98% |
| Dec 31, 2023 | -110.58% |
| Apr 2, 2023 | 3,411.37% |
| Apr 3, 2022 | 87.81% |
| Oct 3, 2021 | -14,555.81% |
| Jul 4, 2021 | -1,130.95% |
| Apr 4, 2021 | -1,998.00% |
| Jan 3, 2021 | -153.67% |
| Oct 4, 2020 | 22.39% |
| Jul 5, 2020 | 90.84% |
| Apr 5, 2020 | 24.68% |